INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:INSP • US4577301090

65.56 USD
-0.04 (-0.06%)
Last: Feb 6, 2026, 03:53 PM
Fundamental Rating

6

Taking everything into account, INSP scores 6 out of 10 in our fundamental rating. INSP was compared to 186 industry peers in the Health Care Equipment & Supplies industry. While INSP has a great health rating, its profitability is only average at the moment. INSP has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year INSP was profitable.
  • In the past year INSP had a positive cash flow from operations.
  • In the past 5 years INSP reported 4 times negative net income.
  • In multiple years INSP reported negative operating cash flow during the last 5 years.
INSP Yearly Net Income VS EBIT VS OCF VS FCFINSP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

  • With an excellent Return On Assets value of 5.52%, INSP belongs to the best of the industry, outperforming 82.80% of the companies in the same industry.
  • INSP has a better Return On Equity (6.69%) than 81.72% of its industry peers.
  • INSP has a better Return On Invested Capital (4.82%) than 75.81% of its industry peers.
Industry RankSector Rank
ROA 5.52%
ROE 6.69%
ROIC 4.82%
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
INSP Yearly ROA, ROE, ROICINSP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • The Profit Margin of INSP (5.05%) is better than 77.96% of its industry peers.
  • The Operating Margin of INSP (4.16%) is better than 68.82% of its industry peers.
  • INSP's Gross Margin of 84.92% is amongst the best of the industry. INSP outperforms 94.62% of its industry peers.
  • In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
Industry RankSector Rank
OM 4.16%
PM (TTM) 5.05%
GM 84.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
INSP Yearly Profit, Operating, Gross MarginsINSP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, INSP has more shares outstanding
  • The number of shares outstanding for INSP has been increased compared to 5 years ago.
  • INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
INSP Yearly Shares OutstandingINSP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
INSP Yearly Total Debt VS Total AssetsINSP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • INSP has an Altman-Z score of 9.56. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
  • INSP has a better Altman-Z score (9.56) than 89.25% of its industry peers.
  • INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.56
ROIC/WACC0.47
WACC10.17%
INSP Yearly LT Debt VS Equity VS FCFINSP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 5.29 indicates that INSP has no problem at all paying its short term obligations.
  • INSP has a better Current ratio (5.29) than 80.65% of its industry peers.
  • A Quick Ratio of 4.01 indicates that INSP has no problem at all paying its short term obligations.
  • INSP has a better Quick ratio (4.01) than 75.81% of its industry peers.
Industry RankSector Rank
Current Ratio 5.29
Quick Ratio 4.01
INSP Yearly Current Assets VS Current LiabilitesINSP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • INSP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 90.65%, which is quite impressive.
  • The Revenue has grown by 16.81% in the past year. This is quite good.
  • INSP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 57.78% yearly.
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.80% on average over the next years. This is quite good.
  • INSP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.14% yearly.
EPS Next Y-17.67%
EPS Next 2Y1.09%
EPS Next 3Y13.97%
EPS Next 5Y18.8%
Revenue Next Year13.49%
Revenue Next 2Y12.16%
Revenue Next 3Y12%
Revenue Next 5Y11.14%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
INSP Yearly Revenue VS EstimatesINSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
INSP Yearly EPS VS EstimatesINSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 32.14, the valuation of INSP can be described as expensive.
  • INSP's Price/Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 73.12% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, INSP is valued at the same level.
  • With a Price/Forward Earnings ratio of 37.08, INSP can be considered very expensive at the moment.
  • 70.43% of the companies in the same industry are more expensive than INSP, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 27.20. INSP is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 32.14
Fwd PE 37.08
INSP Price Earnings VS Forward Price EarningsINSP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, INSP is valued a bit cheaper than the industry average as 71.51% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, INSP is valued cheaper than 89.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.28
EV/EBITDA 27.85
INSP Per share dataINSP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • A more expensive valuation may be justified as INSP's earnings are expected to grow with 13.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.09%
EPS Next 3Y13.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for INSP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INSPIRE MEDICAL SYSTEMS INC

NYSE:INSP (2/6/2026, 3:53:05 PM)

65.56

-0.04 (-0.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-12
Earnings (Next)02-11
Inst Owners111.59%
Inst Owner Change-0.35%
Ins Owners0.74%
Ins Owner Change0.1%
Market Cap1.91B
Revenue(TTM)882.62M
Net Income(TTM)44.56M
Analysts80
Price Target142.79 (117.8%)
Short Float %10.28%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)-1.06%
PT rev (3m)12.32%
EPS NQ rev (1m)31.7%
EPS NQ rev (3m)32.12%
EPS NY rev (1m)34.64%
EPS NY rev (3m)179.78%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)0.4%
Valuation
Industry RankSector Rank
PE 32.14
Fwd PE 37.08
P/S 2.16
P/FCF 19.28
P/OCF 14.25
P/B 2.86
P/tB 2.86
EV/EBITDA 27.85
EPS(TTM)2.04
EY3.11%
EPS(NY)1.77
Fwd EY2.7%
FCF(TTM)3.4
FCFY5.19%
OCF(TTM)4.6
OCFY7.02%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.44
Profitability
Industry RankSector Rank
ROA 5.52%
ROE 6.69%
ROCE 5.27%
ROIC 4.82%
ROICexc 8.98%
ROICexgc 8.98%
OM 4.16%
PM (TTM) 5.05%
GM 84.92%
FCFM 11.2%
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score8
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 276.46%
Cap/Sales 3.95%
Interest Coverage 250
Cash Conversion 270.95%
Profit Quality 221.78%
Current Ratio 5.29
Quick Ratio 4.01
Altman-Z 9.56
F-Score8
WACC10.17%
ROIC/WACC0.47
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
EPS Next Y-17.67%
EPS Next 2Y1.09%
EPS Next 3Y13.97%
EPS Next 5Y18.8%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
Revenue Next Year13.49%
Revenue Next 2Y12.16%
Revenue Next 3Y12%
Revenue Next 5Y11.14%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year658.15%
EBIT Next 3Y123.39%
EBIT Next 5Y70.56%
FCF growth 1Y1118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y401.46%
OCF growth 3YN/A
OCF growth 5YN/A

INSPIRE MEDICAL SYSTEMS INC / INSP FAQ

What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

ChartMill assigns a fundamental rating of 6 / 10 to INSP.


Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?

ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.


How profitable is INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.


What are the PE and PB ratios of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

The Price/Earnings (PE) ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 32.14 and the Price/Book (PB) ratio is 2.86.


What is the financial health of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.